Attenuation of Brain Damage and Cognitive Impairment by Direct Renin Inhibition in Mice With Chronic Cerebral Hypoperfusion
Yi‐Fei Dong(Mie University), Shokei Kim‐Mitsuyama(Kumamoto University), Kenichiro Yata(Neurology, Inc), Daisuke Sueta(Mie University), Hisao Ogawa(Kumamoto University Hospital), Eiichiro Yamamoto(Mie University), Keiichiro Kataoka(Mie University), Hidekazu Tomimoto(Saiseikai Ibaraki Hospital), Kensuke Toyama(Mie University), Nobutaka Koibuchi(Mie University)
Cited by 110
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753